Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

doi:10.1186/1546-0096-6-S1-P9

Pediatric Rheumatology

Volume 6
Suppl 1

Viewing options:

Abstract
Full text
PDF (132KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Salugina SO
Fedorov ES
Alexandrova EN
Novikov AA
Cherkasova MV
Baranov AA
Valogina YA
Nikolaeva TN
Zubova NA

on PubMed

Salugina SO
Fedorov ES
Alexandrova EN
Novikov AA
Cherkasova MV
Baranov AA
Valogina YA
Nikolaeva TN
Zubova NA
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress .

Poster presentation

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

SO Salugina¹, ES Fedorov¹, EN Alexandrova¹, AA Novikov¹, MV Cherkasova¹, AA Baranov², YA Valogina², TN Nikolaeva² and NA Zubova²

¹Institute of Rheumatology RAMS, Moscow, Russian Federation

²Department of Clinical Pathology, Yaroslavl Medical Academy, Yaroslavl, Russian Federation

corresponding author email

from 15^thPaediatric Rheumatology European Society (PreS) Congress
London, UK. 14–17 September 2008

Pediatric Rheumatology 2008, 6(Suppl 1):P9doi:10.1186/1546-0096-6-S1-P9


Published:	15 September 2008

First paragraph (this article has no abstract)

To investigate the diagnostic value and clinical significance of anti-MCV in pts with early JA.